| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9911 |
| Human Intestinal Absorption | HIA+ | 0.9900 |
| Caco-2 Permeability | Caco2+ | 0.7151 |
| P-glycoprotein Substrate | Substrate | 0.7886 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7593 |
| Inhibitor | 0.5358 |
| Renal Organic Cation Transporter | Inhibitor | 0.6894 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6199 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8015 |
| CYP450 2D6 Substrate | Substrate | 0.5494 |
| CYP450 3A4 Substrate | Substrate | 0.6298 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5169 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8812 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.5356 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7374 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8153 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5265 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6201 |
| Non-inhibitor | 0.6721 |
| AMES Toxicity | Non AMES toxic | 0.7465 |
| Carcinogens | Non-carcinogens | 0.9306 |
| Fish Toxicity | High FHMT | 0.9628 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9268 |
| Honey Bee Toxicity | Low HBT | 0.6248 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.5636 |
| Carcinogenicity (Three-class) | Non-required | 0.5404 |